Skip to main content
Clinical Trials/NCT03261323
NCT03261323
Withdrawn
Not Applicable

Evaluating Breast Reconstruction Timing and Risk Reduction Strategies in Patients at a Higher Risk for Developing Breast Reconstruction Surgical Complications: A Prospective Randomized Study

Case Comprehensive Cancer Center1 site in 1 countryMay 31, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Case Comprehensive Cancer Center
Locations
1
Primary Endpoint
optimal timing of reconstruction in patients at a higher risk for developing breast reconstruction surgical complications
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to:

  1. Evaluate whether immediate or delayed reconstruction should be offered for breast reconstruction candidates with higher risk for surgical complications by comparing complications, quality of life, and hospital costs
  2. Determine the efficacy of risk reduction strategies for breast reconstruction patients with higher risk for surgical complications

Detailed Description

Primary Endpoint(s) 1. Define the optimal timing of reconstruction in patients at a higher risk for developing breast reconstruction surgical complications through a randomized prospective cohort 2. Compare immediate and delayed reconstruction outcome metrics through retrospective review Secondary Endpoint(s) 1. Evaluate Quality of life of patients at a higher risk for developing breast reconstruction surgical complications undergoing immediate versus delayed reconstruction. 2. Compare complications and reoperations between immediate versus delayed reconstruction. 3. Compare the hospital costs between immediate versus delayed reconstruction 4. Evaluate the effectiveness of risk reduction strategies

Registry
clinicaltrials.gov
Start Date
May 31, 2019
End Date
July 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects must have histologically or cytologically confirmed breast cancer or indication for prophylactic mastectomy.
  • Subjects must be breast reconstruction candidates using implant based breast reconstruction.
  • Subjects must have a pre-operative risk \>20% complication prediction from the Breast Reconstruction Risk Assessment (BRA) Score for implant-based breast reconstruction candidates
  • Subjects must have the ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

  • Prior breast cancer surgical treatment
  • Prior breast reconstruction
  • Inability to provide written consent

Outcomes

Primary Outcomes

optimal timing of reconstruction in patients at a higher risk for developing breast reconstruction surgical complications

Time Frame: Until 1 year post breast reconstruction

Proportion of patients preferring delayed reconstruction.

Secondary Outcomes

  • Major complications(Until 1 year post breast reconstruction)
  • Minor complications(Until 1 year post breast reconstruction)
  • Number of revision surgeries(Until 1 year post breast reconstruction)
  • Hospital cost of the complete reconstruction treatment(Until 1 year post breast reconstruction)
  • Change in patient satisfaction(Until 1 year post breast reconstruction)

Study Sites (1)

Loading locations...

Similar Trials